ANOTHER Alzheimer's drug fails: Trials of an experimental treatment cancelled two years early
ANOTHER Alzheimer’s drug fails: Trials of a highly-anticipated experimental treatment cancelled two years early Drugmaker Roche has cancelled two clinical trials of an experimental Alzheimer’s drug, crenezumab The pair of trials join over 100 failed Alzheimer’s trials Crenezumab was thought to target harmful protein plaques in the brains of early-stage dementia sufferers But the patients’… Read More »